Athanor Capital’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-26,680
Closed -$1.59M 727
2020
Q2
$1.59M Buy
+26,680
New +$1.65M 0.08% 132
2020
Q1
Sell
-7,300
Closed -$400K 420
2019
Q4
$400K Sell
7,300
-3,200
-30% -$119K 0.02% 275
2019
Q3
$297K Buy
+10,500
New +$385K 0.02% 192

Other funds holding PRNB

Athanor Capital's PRNB Position: Q3 2020 in Review

Athanor Capital sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 26,680 shares — an estimated $1.59M sold.

Athanor Capital first reported a position in PRNB in Q3 2019 and held it in 3 quarters. The position peaked at $1.59M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Athanor Capital reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Athanor Capital sold 26,680 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $1.59M.
  • Athanor Capital first reported a position in Principia Biopharma Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Athanor Capital's Principia Biopharma Inc. Common Stock position peaked at $1.59M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Athanor Capital's 13F filing for Q3 2020, filed 16 Nov 2020.